Last updated: 11/07/2018 11:03:46

Study to analyze the clinical and cost impact of complete and incomplete rotavirus (RV) vaccination

GSK study ID
116829
See study documents
Clinicaltrials.gov ID
NCT01682005
EudraCT ID
Not applicable
EU CT Number
Not applicable
Trial status
Finalized
Finalized
Overview
Eligibility
Locations
Study documents
Results summary
Plain language summaries
Additional information

Trial overview

Official title: Clinical and cost impact of complete and incomplete rotavirus vaccination
Trial description: This study aims to estimate the clinical and cost impact of RV vaccinations (both Rotateq® and Rotarix®) among children aged less than 5 years using insurance claims data from commercial plans and Medicaid low-income population. The impact of incomplete and complete RV vaccination will also be examined, overall and stratified by age (e.g., 6 weeks to 8 months, 8 months and onwards ) and calendar time of RV vaccination (e.g., 2006 onward).
Primary purpose:
Not applicable
Trial design:
Not applicable
Masking:
Not applicable
Allocation:
Not applicable
Primary outcomes:

Estimation of the clinical impact of complete and incomplete RV vaccination among children less than 5 years of age by determining the incidence of first RV episode.

Timeframe: During the study period (from January 2000 up to June 2011), an expected average of 1 year and 6 months.

Estimation of the clinical impact of complete and incomplete RV vaccination among children less than 5 years of age by calculating the RV-related resource utilization.

Timeframe: During the study period (from January 2000 up to June 2011), an expected average of 1 year and 6 months.

Estimation of the clinical impact of complete and incomplete RV vaccination among children less than 5 years of age by calculating the diarrhea-related resource utilization.

Timeframe: During the study period (from January 2000 up to June 2011), an expected average of 1 year and 6 months.

Estimation of the cost impact of complete and incomplete RV vaccination among children less than 5 years of age by determining the first RV episode costs.

Timeframe: During the study period (from January 2000 up to June 2011), an expected average of 1 year and 6 months.

Estimation of the cost impact of complete and incomplete RV vaccination among children less than 5 years of age by calculating the RV-related healthcare costs.

Timeframe: During the study period (from January 2000 up to June 2011), an expected average of 1 year and 6 months.

Estimation of the cost impact of complete and incomplete RV vaccination among children less than 5 years of age by calculating the diarrhea-related healthcare costs.

Timeframe: During the study period (from January 2000 up to June 2011), an expected average of 1 year and 6 months.

Estimation of the clinical impact of complete and incomplete RV vaccination among children less than 5 years of age by calculating the first diarrhea episode costs.

Timeframe: During the study period (from 2000 up to June 2011).

Secondary outcomes:
Not applicable
Interventions:
Other: Data interpretation
Enrollment:
1
Observational study model:
Cohort
Primary completion date:
Not applicable
Time perspective:
Retrospective
Clinical publications:
Krishnarajah G et al. (2016) Public health impact of complete and incomplete rotavirus vaccination among commercially and Medicaid insured children in the United States. PLoS One. 11(1);e0145977.
Medical condition
Infections, Rotavirus
Product
SB444563
Collaborators
Not applicable
Study date(s)
August 2012 to August 2013
Type
Observational
Phase
Not applicable

Participation criteria

Sex
Female & Male
Age
Not applicable - 5 years
Accepts healthy volunteers
Yes
  • Continuously enrolled from birth.
  • (Note: Due to the absence of birth dates in insurance claims data, this inclusion criterion will be met if a child’s year of first enrollment and year of birth are the same. If so, then the date of first enrollment will be used as proxy for date of birth.)
  • Enrolled in capitation-based health plans.
  • For MarketScan Commercial, residence in states with universal vaccination programs that include the RV vaccine or where RV vaccine inclusion cannot be ascertained (i.e., Alaska, Idaho, Massachusetts, Maine, North Dakota, New Hampshire, New Mexico, Oregon, Rhode Island, Vermont, Washington, Wisconsin, and Wyoming).
Inclusion and exclusion criteria
Inclusion criteria:

    Continuously enrolled from birth. (Note: Due to the absence of birth dates in insurance claims data, this inclusion criterion will be met if a child’s year of first enrollment and year of birth are the same. If so, then the date of first enrollment will be used as proxy for date of birth.)

    • Received both medical and pharmacy benefits.
Exclusion criteria:

    Enrolled in capitation-based health plans.

    • For MarketScan Commercial, residence in states with universal vaccination programs that include the RV vaccine or where RV vaccine inclusion cannot be ascertained (i.e., Alaska, Idaho, Massachusetts, Maine, North Dakota, New Hampshire, New Mexico, Oregon, Rhode Island, Vermont, Washington, Wisconsin, and Wyoming).
    • Lost to follow-up or had RV prior to 6 weeks of age.

Trial location(s)

No location data available.

Study documents

Clinical study report
Available language(s): English
Download document(s)
Scientific result summary
Available language(s): English
Download document(s)
Protocol
Available language(s): English
Download document(s)

If you wish to request for full study report, please contact - [email protected]

Results overview

Refer to study documents

Recruitment status
Finalized
Actual primary completion date
Not applicable
Actual study completion date
2013-23-08

Plain language summaries

Not applicable. GSK’s transparency policy provides for Plain Language Summaries for Interventional studies.

Additional information about the trial

Not applicable
Participate in clinical trial
Access to clinical trial data by researchers
Visit website